Company intelligence / Profile preview

NEXT Molecular Analytics

Chester, Virginia, United States

Ownership: Private
Employees: ~30
Development stage: Other

Overview

NEXT Molecular Analytics is a contract research organization (CRO) headquartered in Chester, Virginia. The company provides integrated bio-molecular analysis services, including clinical testing using molecular and biochemical techniques, with specific expertise in pharmacogenomics and cancer genetics. Operating for over 23 years, it serves investigators and organizations in the biotech and pharmaceutical sectors. The company employs an estimated 10-50 people and maintains diverse employee tenure levels, with 38% having 3-4 years of experience and 38% having 8-10 years of experience.

Industry: Contract Research Organization

Beyond the preview

Go deeper on NEXT Molecular Analytics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NEXT Molecular Analytics.

Explore the full profile